Rubber stoppers are not sterile surfaces
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomized placebo-controlled trial
Nausea, vomiting, diarrhea, abdominal pain, and constipation occur frequently with both formulations, typically emerging during dose escalation and often diminishing over time as patients develop tolerance
If needed, the weekly injection day can be changed provided at least 3 days (72 hours) have elapsed since the last dose
Comprehensive Evaluation We will conduct a comprehensive evaluation, including blood tests and other diagnostic measures, to assess your overall health and determine if Semaglutide is a suitable option for you